We are conducting a clinical research study on an investigational, new version of the Implantable Miniature Telescope (IMT), called the SING IMTTM (Smaller-Incision New- Generation). The study will evaluate improvements in visual acuity and safety of the device in people living with late-stage AMD in both eyes.
The purpose of the implant is to enable qualified patients to recognize and identify objects that they may not otherwise be able to see, as a result of their central vision loss due to AMD.
Already approved in Europe, the SING IMTTM design differs from the original device since it can be inserted through a device delivery system that allows for a smaller incision and less complicated surgery.
Interested in participating?
We are currently conducting this study nationwide with new locations coming soon. Take a look at our current locations below to find out if we have a study location near you.
If transportation is needed, in many situations it can be provided both to and from the study facility at no cost to you.
If you are interested in referring late-stage AMD patients to the CONCERTO study, would like to discuss eligibility, and to answer any questions, please reach out to Dr. Rebecca Kammer rkammer@samsaravision.com. To access the Patient Guide and Concerto Study Brochure, click the button below to download.
Click the button below to download today. For additional questions about the Concerto study, patient referrals and study participation please contact
Dr. Rebecca Kammer rkammer@samsaravision.com
If you want to learn more, or to see if you or a loved one qualifies for the CONCERTO study:
Fill out the contact information. You will be contacted for a pre-screening discussion within 72 hours.
Please take a moment to answer some questions and provide your contact information.
This information is shared with the patient recruitment team so that they can contact you about the study, answer any questions you may have, and schedule your first study visit.
Remember that your participation is completely voluntary and that you can choose not to participate at any time.
We look forward to speaking with you soon.
Fields with an asterisks (*) are required.
Late-stage age-related macular degeneration (AMD) is an advanced form of AMD, where damage to the central vision area of the retina, the macula, occurs. Late-stage AMD is the leading cause of irreversible vision loss for people over 60 years old.
All of your study visits and rehabilitation are covered and there is no need to bill your insurance, and you can continue with your own provider for general care. In fact, you will be compensated for your study-related time and travel.
In many situations transportation can be provided both to and from the study facility.
This is an outpatient procedure performed during cataract surgery, you would go home within a few hours after surgery. The recovery from surgery is relatively rapid. Any discomfort from the surgical procedure generally subsides within several days.
The telescopic implant does not limit your natural eye movements and does not require you to move your entire head, as you have to do with external magnifying appliances. You can use natural eye movements to see things that are close and far away from you, such as reading printed materials or watching television. As a tradeoff to improving central vision, the peripheral (side) vision will be restricted in the eye with the telescope implant. However, your peripheral vision will stay the same as before the surgery in your non-implanted eye.
The telescope is virtually unnoticeable to others because it is implanted totally inside the eye, and mostly covered by the colored portion of the eye (iris).